Wearable Injectors Market

Wearable Injectors Market Overview

The global Wearable Injectors Market size was valued at USD 7.17 billion in 2023 and is predicted to reach USD 17.58 billion by 2030 with a CAGR of 13.8% from 2024-2030. Wearable injectors also known as on-body injectors market represents a specialized segment within the medical device industry focused on innovative drug delivery solutions.

This segment deals with devices that are designed to meet the growing demand for convenient, patient-centric healthcare options, particularly for conditions requiring frequent medication administration, ultimately contributing to improved patient care and business growth in the pharmaceutical and healthcare sectors.

The features of these automated injectors include programmable dosing schedules, automatic needle insertion and retraction mechanisms, and connectivity options for remote monitoring and data collection.

Moreover, the wearable injectors market offers substantial opportunities for growth and differentiation through continuous product innovation, enhanced user experience, and strategic industry positioning.

Market Dynamics and Trends

The rising prevalence of chronic diseases such as diabetes and cardiovascular disease (CVD) requires regular medications and monitoring, driving the wearable injectors market demand. These devices allow patients to receive their treatments at home, improving both convenience and adherence to therapy.

As per the report published by World Health Organisation, approximately 41 million people worldwide lost their lives each year due to chronic diseases. With such increase in the number of patients suffering from these diseases, the demand for advanced treatment is on rise, driving the growth of the market.

Additionally, the rising government spendings across the globe to modernise the healthcare infrastructure drives demand for upgraded technologies and latest equipment including wearable patches and injectors. These injectors improve the treatment efficiency by delivering precise doses of medication directly to patients in a controlled and consistent manner, minimizing the risk of human error.

According to a report published by the Ministry of Health and Family Welfare, the budget for medical spending in India is reached approximately USD 10.70 billion in 2023, up from USD 9.49 billion in 2022.

Additionally, the Government of Australia’s spending on healthcare sector in 2022 was around USD 71.9 billion. With such increase in government spending, the government aims to modernize the healthcare system to be equipped with the latest technologies.

Moreover, the increasing incidence of age-related health issue such as diabetes, heart disease and kidney disease across the globe drives the demand for wearable injectors. These devices enable at-home administration of medications, improving compliance and quality of life for elderly patients who may have difficulty in visiting healthcare facilities regularly.

As per the report published by Endocrine Society, in 2022, an estimated of 33% of individuals aged 65 and older across the world were living with diabetes. This rise in elderly population drives the demand for advanced treatment solutions boosting the wearable injectors market expansion.

However, the technical issues with the injectors such as low battery life, device malfunctions, and inconsistent drug delivery restrain the growth of the market. On the contrary, the integration of wearable injectors with the smart devices such as mobile phones and cloud monitoring technologies is anticipated to create future opportunity for the market.

Smart devices enhance injectors by enabling real-time monitoring and improved patient engagement. The integration of cloud monitoring technologies further supports patient health by allowing remote tracking, real-time data analysis, and timely adjustments to treatment plans.

Market Segmentations and Scope of the Study

The wearable injectors market report is segmented by type, technology, application, end-user and region. On the basis of type, the market is bifurcated into on-body and off-body. On the basis of technology, the market is segmented by spring, motor drive, expanding battery, and rotary pump. On the basis of indications, the market is divided into diabetes, immuno- oncology, cardiovascular, chronic pain, and others. On the basis of end-user, the market is classified by hospital, clinic, homecare and others. Regional breakdown and analysis of each of the aforesaid segments includes regions comprising of North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis

Asia-Pacific dominates the wearable injectors market share and is expected to continue its dominance during the forecast period. The rising number of elderly individuals, coupled with an increase in age-related health issue drives the demand for on-body injectors. These devices enable less frequent dosing that reduces the number of needle sticks and makes the treatment process more convenient.

As per the latest report published by the Asian Development Bank, the people aged 60 or above is expected to reach 1.3 billion by 2050 in the Asia-Pacific region. With such rise in aging population there is an increase in need for wearable injectors to manage age related health conditions and improve patient outcomes.

Moreover, the increase in rate of chronic diseases such as diabetes and CVD requires regular and precise medication further driving the demand for on-body injectors. On-body injectors provide a reliable and convenient method for administering medications, offering solutions for managing chronic illnesses and leading to better health outcomes and an improved quality of life.

As per the report published by National Library of Medicine, in June 2023, approximately 330 million individuals in China were affected by CVD including 13 million strokes and 11.39 million coronary heart disease. With such vast number of people suffering from chronic illness, the demand for on-body injectors is on rise.

On the other hand, North-America shows a steady rise in the wearable injectors market trends during the forecast period. This is attributed to the government spendings in advancing the healthcare infrastructure for its people.

According to a report from the Centers for Medicare & Medicaid Services (CMS), the medical spendings in the U.S reached around USD 4.84 trillion in 2023 from USD 4.50 trillion in 2022.  Moreover, the presence of key players such as Tandem Diabetes Care, BD Liberats and Pfizer are adopting various strategies including acquisition that further boosts the wearable injectors market growth.

For instance, in March 2023, Tandem Diabetes Care acquired Capillary Biomedical to enhance their product offerings and innovation. This acquisition aims to develop new infusion set solutions that extend wear time, reduce occlusions, and minimize waste, thereby improving user experience. This integration advances the market for wearable injectors, particularly benefiting patients with diabetes by providing more reliable and convenient treatment options.

Competitive Landscape

Various market players operating in the wearable injectors industry are Pfizer Inc., Gerresheimer AG, AbbVie Inc., BD Libertas, West Pharmaceutical Services, Inc., Ypsomed AG, Amgen Inc., Medtronic PLC, Insulet Corporation, Tandem Diabetes Care, Inc., Coherus BioSciences, Eli Lilly and Company, Medtrum Technologies, Enable Injections, CCBio and others. These companies are adopting various strategies such as product launches and acquisition to remain dominant in the market.

For instance, February 2024, Coherus BioSciences launched UDENYCA ONBODY an on-body injector designed for patients undergoing chemotherapy. By this launch the company aims to provide a convenient treatment option for patients, especially those living far from care centers.

Additionally, in December 2023, Ypsomed launched 10mL YpsoDose patch injector. The product offers patient-centric design with pre-filled and pre-assembled options and delivers pharmaceutical companies and patients a reliable, user-friendly drug delivery solution.

Moreover, in February 2023, Insulet acquired Automated Glucose Control LLC to enhance its Omnipod 5 wearable injector system. With this acquisition the company aims to develop advanced solutions for people with diabetes in the future.

Key Benefits

• The report provides quantitative analysis and estimations of the wearable injectors market from 2024 to 2030, which assists in identifying the prevailing industry opportunities.

• The study comprises a deep-dive analysis of the current and future wearable injectors market trends to depict the prevalent investment pockets in the industry.

• Information related to key drivers, restraints, and opportunities and their impact on the market is provided in the report. 

• Competitive analysis of the key players, along with their market share is provided in the report.

• SWOT analysis and Porters Five Forces model is elaborated in the study.

• Value chain analysis in the market study provides a clear picture of roles of stakeholders.

Wearable Injectors Market Key Segments

By Type

• On-body

• Off-body 

By Technology

• Spring

• Motor Drive

• Expanding Battery

• Rotary Pump

By Application

• Diabetes

• Immuno- Oncology

• Cardiovascular

• Chronic Pain

• Others

By End-User

• Hospital

• Clinic

• Homecare

• Others 

By Region

• North America

  • The U.S.

  • Canada

  • Mexico

• Europe

  • The UK

  • Germany

  • France        

  • Italy        

  • Spain        

  • Denmark        

  • Netherlands        

  • Finland        

  • Sweden        

  • Norway        

  • Russia

  • Rest of Europe

• Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Singapore

  • Taiwan

  • Thailand

  • Rest of Asia-Pacific 

• RoW

  • Latin America

  • Middle East 

  • Africa

REPORT SCOPE AND SEGMENTATION

Parameters	Details
Market Size in 2023	USD 7.17 billion
Revenue Forecast in 2030	USD 17.58 billion
Growth Rate	CAGR of 13.8% from 2024 to 2030
Analysis Period	2023–2030
Base Year Considered	2023
Forecast Period	2024–2030
Market Size Estimation	Billion (USD)
Growth Factors	The increasing chronic diseases is driving the growth of the market. The rising government spendings in healthcare sector fuels the market growth. The increase incidence of age-related health issues further boosts the growth of the market.
Countries Covered	28
Companies Profiled	15
Market Share	Available for 15 companies
Customization Scope	Free customization (equivalent to up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope.
Pricing and Purchase Options	Avail customized purchase options to meet your exact research needs.

Key Players

• Pfizer Inc.

• Gerresheimer AG

• AbbVie Inc.

• BD Libertas

• West Pharmaceutical Services, Inc.

• Ypsomed AG

• Amgen Inc.

• Medtronic PLC

• Insulet Corporation

• Tandem Diabetes Care, Inc.

• Coherus BioSciences

• Eli Lilly and Company

• Medtrum Technologies

• Enable Injections

• CCBio